# TaskUs, Inc.: financial statements, quarterly

TASK · Nasdaq · CIK 1829864 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/task.md) · [Financials](/companies/task/financials.md) · [Filings](/companies/task/filings.md) · [Insiders](/companies/task/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/task/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [226](/filings/0001829864-24-000162.md) | [234 d](/filings/0001829864-26-000012.md) | [227](/filings/0001829864-25-000082.md) | [238](/filings/0001829864-25-000118.md) | [255](/filings/0001829864-25-000132.md) | [274 d](/filings/0001829864-26-000012.md) | [278](/filings/0001829864-26-000113.md) | [294](/filings/0001829864-26-000149.md) | [299](/filings/0001829864-25-000132.md) | [313 d](/filings/0001829864-26-000012.md) | [306](/filings/0001829864-26-000113.md) | [309](/filings/0001829864-26-000149.md) |
| Selling, general and administrative | $m | [57.1](/filings/0001829864-24-000162.md) | [48.9 d](/filings/0001829864-26-000012.md) | [52.9](/filings/0001829864-25-000082.md) | [56.3](/filings/0001829864-25-000118.md) | [62.7](/filings/0001829864-25-000132.md) | [67.8 d](/filings/0001829864-26-000012.md) | [57.4](/filings/0001829864-26-000113.md) | [68.4](/filings/0001829864-26-000149.md) | [59.7](/filings/0001829864-25-000132.md) | [59.4 d](/filings/0001829864-26-000012.md) | [58.3](/filings/0001829864-26-000113.md) | [54.6](/filings/0001829864-26-000149.md) |
| Operating income | $m | [22.9](/filings/0001829864-24-000162.md) | [31.5 d](/filings/0001829864-26-000012.md) | [23.6](/filings/0001829864-25-000082.md) | [22.7](/filings/0001829864-25-000118.md) | [24.2](/filings/0001829864-25-000132.md) | [22.0 d](/filings/0001829864-26-000012.md) | [34.2](/filings/0001829864-26-000113.md) | [30.4](/filings/0001829864-26-000149.md) | [37.9](/filings/0001829864-25-000132.md) | [38.1 d](/filings/0001829864-26-000012.md) | [34.2](/filings/0001829864-26-000113.md) | [33.3](/filings/0001829864-26-000149.md) |
| Interest expense | $m | [5.7](/filings/0001829864-23-000123.md) | [5.6 d](/filings/0001829864-24-000011.md) | [5.5](/filings/0001829864-24-000085.md) | [5.5](/filings/0001829864-25-000118.md) | [5.5](/filings/0001829864-25-000132.md) | [5.0 d](/filings/0001829864-26-000012.md) | [4.7](/filings/0001829864-26-000113.md) | [4.6](/filings/0001829864-26-000149.md) | [4.6](/filings/0001829864-25-000132.md) | [4.5 d](/filings/0001829864-26-000012.md) | [5.3](/filings/0001829864-26-000113.md) | [8.8](/filings/0001829864-26-000149.md) |
| Income tax | $m | [4.6](/filings/0001829864-24-000162.md) | [11.4 d](/filings/0001829864-26-000012.md) | [6.5](/filings/0001829864-25-000082.md) | [7.3](/filings/0001829864-25-000118.md) | [5.1](/filings/0001829864-25-000132.md) | [9.4 d](/filings/0001829864-26-000012.md) | [8.6](/filings/0001829864-26-000113.md) | [7.0](/filings/0001829864-26-000149.md) | [10.3](/filings/0001829864-25-000132.md) | [8.4 d](/filings/0001829864-26-000012.md) | [11.9](/filings/0001829864-26-000113.md) | [7.5](/filings/0001829864-26-000149.md) |
| Net income | $m | [9.8](/filings/0001829864-24-000162.md) | [16.3 d](/filings/0001829864-26-000012.md) | [11.7](/filings/0001829864-25-000132.md) | [12.6](/filings/0001829864-25-000132.md) | [12.7](/filings/0001829864-25-000132.md) | [8.9 d](/filings/0001829864-26-000012.md) | [21.1](/filings/0001829864-26-000149.md) | [20.0](/filings/0001829864-26-000149.md) | [31.4](/filings/0001829864-25-000132.md) | [29.7 d](/filings/0001829864-26-000012.md) | [24.3](/filings/0001829864-26-000149.md) | [22.0](/filings/0001829864-26-000149.md) |
| Diluted EPS | $ per share | [0.10](/filings/0001829864-24-000162.md) | not reported | [0.13](/filings/0001829864-25-000082.md) | [0.14](/filings/0001829864-25-000118.md) | [0.14](/filings/0001829864-25-000132.md) | not reported | [0.23](/filings/0001829864-26-000113.md) | [0.22](/filings/0001829864-26-000149.md) | [0.34](/filings/0001829864-25-000132.md) | not reported | [0.26](/filings/0001829864-26-000113.md) | [0.24](/filings/0001829864-26-000149.md) |
| Basic EPS | $ per share | [0.11](/filings/0001829864-24-000162.md) | not reported | [0.13](/filings/0001829864-25-000082.md) | [0.14](/filings/0001829864-25-000118.md) | [0.14](/filings/0001829864-25-000132.md) | not reported | [0.23](/filings/0001829864-26-000113.md) | [0.22](/filings/0001829864-26-000149.md) | [0.35](/filings/0001829864-25-000132.md) | not reported | [0.27](/filings/0001829864-26-000113.md) | [0.24](/filings/0001829864-26-000149.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [115](/filings/0001829864-23-000123.md) | [126](/filings/0001829864-25-000016.md) | [165](/filings/0001829864-24-000085.md) | [171](/filings/0001829864-24-000138.md) | [180](/filings/0001829864-24-000162.md) | [192](/filings/0001829864-26-000012.md) | [197](/filings/0001829864-25-000082.md) | [182](/filings/0001829864-25-000118.md) | [210](/filings/0001829864-25-000132.md) | [212](/filings/0001829864-26-000149.md) | [152](/filings/0001829864-26-000113.md) | [180](/filings/0001829864-26-000149.md) |
| Current assets | $m | [325](/filings/0001829864-23-000123.md) | [329](/filings/0001829864-25-000016.md) | [356](/filings/0001829864-24-000085.md) | [379](/filings/0001829864-24-000138.md) | [419](/filings/0001829864-24-000162.md) | [435](/filings/0001829864-26-000012.md) | [456](/filings/0001829864-25-000082.md) | [471](/filings/0001829864-25-000118.md) | [492](/filings/0001829864-25-000132.md) | [509](/filings/0001829864-26-000149.md) | [449](/filings/0001829864-26-000113.md) | [476](/filings/0001829864-26-000149.md) |
| Total assets | $m | [871](/filings/0001829864-23-000123.md) | [864](/filings/0001829864-25-000016.md) | [875](/filings/0001829864-24-000085.md) | [886](/filings/0001829864-24-000138.md) | [942](/filings/0001829864-24-000162.md) | [953](/filings/0001829864-26-000012.md) | [985](/filings/0001829864-25-000082.md) | [1,018](/filings/0001829864-25-000118.md) | [1,037](/filings/0001829864-25-000132.md) | [1,051](/filings/0001829864-26-000149.md) | [982](/filings/0001829864-26-000113.md) | [998](/filings/0001829864-26-000149.md) |
| Current liabilities | $m | [111](/filings/0001829864-23-000123.md) | [102](/filings/0001829864-25-000016.md) | [106](/filings/0001829864-24-000085.md) | [117](/filings/0001829864-24-000138.md) | [139](/filings/0001829864-24-000162.md) | [152](/filings/0001829864-26-000012.md) | [159](/filings/0001829864-25-000082.md) | [166](/filings/0001829864-25-000118.md) | [170](/filings/0001829864-25-000132.md) | [163](/filings/0001829864-26-000149.md) | [163](/filings/0001829864-26-000113.md) | [162](/filings/0001829864-26-000149.md) |
| Total liabilities | $m | [442](/filings/0001829864-23-000123.md) | [423](/filings/0001829864-25-000016.md) | [420](/filings/0001829864-24-000085.md) | [426](/filings/0001829864-24-000138.md) | [452](/filings/0001829864-24-000162.md) | [456](/filings/0001829864-26-000012.md) | [465](/filings/0001829864-25-000082.md) | [474](/filings/0001829864-25-000118.md) | [470](/filings/0001829864-25-000132.md) | [451](/filings/0001829864-26-000149.md) | [707](/filings/0001829864-26-000113.md) | [698](/filings/0001829864-26-000149.md) |
| Long-term debt | $m | [259](/filings/0001829864-23-000123.md) | [256](/filings/0001829864-25-000016.md) | [253](/filings/0001829864-24-000085.md) | [250](/filings/0001829864-24-000138.md) | [246](/filings/0001829864-24-000162.md) | [241](/filings/0001829864-26-000012.md) | [236](/filings/0001829864-25-000082.md) | [231](/filings/0001829864-25-000118.md) | [226](/filings/0001829864-25-000132.md) | [220](/filings/0001829864-26-000149.md) | [475](/filings/0001829864-26-000113.md) | [469](/filings/0001829864-26-000149.md) |
| Current portion of debt | $m | [6.4](/filings/0001829864-23-000123.md) | [8.1](/filings/0001829864-25-000016.md) | [9.7](/filings/0001829864-24-000085.md) | [11.4](/filings/0001829864-24-000138.md) | [13.1](/filings/0001829864-24-000162.md) | [14.8](/filings/0001829864-26-000012.md) | [16.5](/filings/0001829864-25-000082.md) | [18.2](/filings/0001829864-25-000118.md) | [19.9](/filings/0001829864-25-000132.md) | [21.6](/filings/0001829864-26-000149.md) | [17.0](/filings/0001829864-26-000113.md) | [23.3](/filings/0001829864-26-000149.md) |
| Shareholders' equity | $m | [429](/filings/0001829864-24-000162.md) | [441](/filings/0001829864-26-000012.md) | [455](/filings/0001829864-25-000132.md) | [460](/filings/0001829864-25-000132.md) | [490](/filings/0001829864-25-000132.md) | [497](/filings/0001829864-26-000149.md) | [520](/filings/0001829864-26-000149.md) | [545](/filings/0001829864-26-000149.md) | [568](/filings/0001829864-25-000132.md) | [600](/filings/0001829864-26-000149.md) | [275](/filings/0001829864-26-000149.md) | [300](/filings/0001829864-26-000149.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [21.7 d](/filings/0001829864-24-000162.md) | [39.8 d](/filings/0001829864-26-000012.md) | [51.2](/filings/0001829864-25-000082.md) | [30.0 d](/filings/0001829864-25-000118.md) | [17.0 d](/filings/0001829864-25-000132.md) | [40.7 d](/filings/0001829864-26-000012.md) | [36.3](/filings/0001829864-26-000113.md) | [17.0 d](/filings/0001829864-26-000149.md) | [54.3 d](/filings/0001829864-25-000132.md) | [29.7 d](/filings/0001829864-26-000012.md) | [46.3](/filings/0001829864-26-000113.md) | [43.1 d](/filings/0001829864-26-000149.md) |
| Capital expenditure | $m | [7.9 d](/filings/0001829864-24-000162.md) | [8.1 d](/filings/0001829864-26-000012.md) | [3.6](/filings/0001829864-25-000082.md) | [4.5 d](/filings/0001829864-25-000118.md) | [10.7 d](/filings/0001829864-25-000132.md) | [20.3 d](/filings/0001829864-26-000012.md) | [14.5](/filings/0001829864-26-000113.md) | [17.0 d](/filings/0001829864-26-000149.md) | [12.3 d](/filings/0001829864-25-000132.md) | [19.7 d](/filings/0001829864-26-000012.md) | [10.2](/filings/0001829864-26-000113.md) | [10.5 d](/filings/0001829864-26-000149.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001829864-26-000113.md) | [0.0 d](/filings/0001829864-26-000149.md) | not reported | not reported | [333](/filings/0001829864-26-000113.md) | [0.0 d](/filings/0001829864-26-000149.md) |
| Share repurchases | $m | [48.3 d](/filings/0001829864-24-000162.md) | [19.3 d](/filings/0001829864-26-000012.md) | [2.6](/filings/0001829864-25-000082.md) | [12.5 d](/filings/0001829864-25-000118.md) | [0.4 d](/filings/0001829864-25-000132.md) | [3.1 d](/filings/0001829864-26-000012.md) | [9.7](/filings/0001829864-26-000113.md) | [18.1 d](/filings/0001829864-26-000149.md) | [0.0 d](/filings/0001829864-25-000132.md) | [(0.0) d](/filings/0001829864-26-000012.md) | [0.0](/filings/0001829864-26-000113.md) | [0.0 d](/filings/0001829864-26-000149.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [102](/filings/0001829864-23-000123.md) | [101](/filings/0001829864-24-000085.md) | [98.2](/filings/0001829864-24-000138.md) | [94.0](/filings/0001829864-24-000162.md) | [91.8](/filings/0001829864-25-000082.md) | [91.6](/filings/0001829864-25-000118.md) | [92.6](/filings/0001829864-25-000132.md) | [93.7](/filings/0001829864-26-000113.md) | [92.6](/filings/0001829864-26-000149.md) | [93.1](/filings/0001829864-25-000132.md) | [93.1](/filings/0001829864-26-000113.md) | [92.5](/filings/0001829864-26-000149.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.